Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and ritonavir

n-methyl-3,4-methylenedioxyamphetamine has been researched along with ritonavir in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (62.50)	18.2507
2000's	2 (25.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dansette, PM; Fontana, E; Poli, SM	1
Henry, JA; Hill, IR	1
de la Torre, R; Farré, M; Mas, M; Ortuño, J; Segura, J	1
Brauer, RB; Griese, EU; Hellinger, A; Schwab, M; Seyringer, E	1
Harrington, RD; Hooton, TM; Horn, JR; Woodward, JA	1
Baker, R; Bowers, M	1
Bertelsen, KM; Greenblatt, DJ; von Moltke, LL	1
de la Torre, R; Farré, M; Nolla, J; Papaseit, E; Pérez-Mañá, C; Pujadas, M; Vázquez, A	1

Reviews

1 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and ritonavir

Article	Year
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Current drug metabolism, 2005, Volume: 6, Issue:5 Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic	2005

Other Studies

7 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and ritonavir

Article	Year
Fatal interaction between ritonavir and MDMA. Lancet (London, England), 1998, Nov-28, Volume: 352, Issue:9142 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Interactions; Drug Therapy, Combination; Fatal Outcome; Hallucinogens; Heart Arrest; Humans; Liver Diseases, Alcoholic; Male; N-Methyl-3,4-methylenedioxyamphetamine; Ritonavir	1998
Fatal MDMA intoxication. Lancet (London, England), 1999, Feb-13, Volume: 353, Issue:9152 Topics: Anti-HIV Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Ritonavir	1999
Fatal MDMA intoxication. Lancet (London, England), 1999, Feb-13, Volume: 353, Issue:9152 Topics: Adolescent; Anti-HIV Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Ritonavir	1999
Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate. Archives of internal medicine, 1999, Oct-11, Volume: 159, Issue:18 Topics: Acquired Immunodeficiency Syndrome; Adrenergic Uptake Inhibitors; Adult; Anesthetics; Drug Synergism; Hallucinogens; HIV Protease Inhibitors; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Ritonavir; Saquinavir; Sodium Oxybate	1999
Ritonavir and ecstasy. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1997 Topics: Cocaine; Cytochrome P-450 Enzyme System; Designer Drugs; Drug Interactions; Heroin; HIV Infections; HIV Protease Inhibitors; Humans; Methadone; N-Methyl-3,4-methylenedioxyamphetamine; Ritonavir	1997
Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers. Biopharmaceutics & drug disposition, 2006, Volume: 27, Issue:5 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cell Line; Dogs; Humans; Indomethacin; N-Methyl-3,4-methylenedioxyamphetamine; Probenecid; Progesterone; Propionates; Quinolines; Rhodamine 123; Ritonavir; Verapamil	2006
Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV). Intensive care medicine, 2012, Volume: 38, Issue:7 Topics: Blood Component Transfusion; Contraindications; Drug Interactions; Fever; Fluid Therapy; Hallucinogens; HIV Protease Inhibitors; HIV Seropositivity; Humans; Intensive Care Units; Male; N-Methyl-3,4-methylenedioxyamphetamine; Renal Dialysis; Respiration, Artificial; Ritonavir; Seizures; Survival; Unconsciousness; Young Adult	2012